HYPOGONADISM IN METABOLIC SYNDROME PATIENTS
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 1
Abstract
Introduction. Previous studies have shown a high prevalence of low levels of the endogenous sexual hormones in patients with metabolic syndrome (MetS). The aim of this study was to analyze the prevalence of hypogonadism in MetS patients. Materials and Methods. We analyzed the relationship between testosterone levels and components of metabolic syndrome in 381 patients. These patients were divided into two groups: group A – patients with metabolic syndrome (MetS) and hypogonadism (MetS+T) and group B – patients with metabolic syndrome without hypogonadism (MetS-T). Overweight was defined as BMI 26-29.9kg/m2. Obesity was defined as BMI≥30 kg/m2. Male hypogonadism or androgen deficiency has been defined as a maximum level of total testosterone up to 3 ng/ml. Results. There were no significant age differences between groups (59.8±8.38 versus 58.31±7.47 years p=0.06). Prevalence of hypogonadism in metabolic syndrome patients was 33.5% (n=128). There were no significant differences between groups in terms of body weight, waist circumference, hip circumference, BMI and blood pressure between groups (all p>0.05). Patients with hypogonadism had significantly higher levels of triglycerides, FPI, HOMA-IR (all p<0.05) and smaller HDL-cholesterol and SHBG (all p<0.05). There was a significant decline in testosterone concentration with increase in age and BMI. 88.3% of the diabetic patients (n=113) had hypogonadism (p=0.0001). Hypogonadism was present in 25% patients (n=32) with 3 components of MetS, 43.8% (n=56) patients with 4 componets of MetS and in 31.2% (n=40) patients with 5 components of MetS (p=0.0001). Conclusions. Hypogonadism is a common occurrence in subjects with MetS. Males with MetS with or without diabetes have lower serum testosterone. Patients with MetS should be investigated for clinical and biochemical signs of hypogonadism and patients with hypogonadism should be investigated for signs of metabolic syndrome.
Authors and Affiliations
Florin Rusu, Emilia Rusu, Gabriela Radulian, Georgiana Enache, Mariana Jinga, Viorel Jinga, Carmen Radu, Dan Mischianu, Dan Mircea Cheţa
Keywords
Related Articles
- EP ID EP155377
- DOI -
- Views 100
- Downloads 0
SODIUM-GLUCOSE TRANSPORTER 2 INHIBITION – A POTENTIAL OPTION FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Glucose homeostasis is maintained by the balanced actions of glucose absorption, gluconeogenesis, glycogenolysis, glucose consumption, glucose excretion and glucose reabsorption. The human kidney is involved in glucose r...
MANAGEMENT OF HYPERTENSION IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE
Diabetes mellitus and hypertension are the most common causes of end-stage renal disease. Blood pressure goals in patients with diabetic kidney disease are <130/80 mmHg. The first line therapy for hypertension in thes...
THE EPIDEMIOLOGY OF DIABETIC NEUROPATHY
One of the major complications of diabetes mellitus (DM) is represented by the diabetic neuropathy (DN). Different peripheral nerves may be affected through many pathological processes and, therefore, there are many type...
CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER IN DIABETES MELLITUS PATIENTS
Diabetes mellitus (DM) and chronic kidney disease (CKD) are two diseases with increasing prevalence and adverse outcomes that represent an international health problem. Chronic kidney disease- mineral and bone diso...
FEEDING BEHAVIOR EVALUATION IN PERSONS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS IN SALAJ COUNTY
The paper analyzes the behavior and eating habits of people newly diagnosed with type 2 diabetes in Sǎlaj county. As a working method a questionnaire was used to assess the nutrition and eating habits; the sample chosen...